Immunological response to (1,4)-α-d-glucan in the lung and spleen of endotoxin-stimulated juvenile rats

Basic and Clinical Pharmacology and Toxicology

Volumn 105, Issue 5, 2009, Pages 301-306

  Velazquez, Ectis A ^a   Kimura, Dai ^a   Torbati, Dan ^a   Ramachandran, Cheppail ^a   Totapally, Balagangadhar R ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(1,4) ALPHA DEXTRO GLUCAN; ESCHERICHIA COLI ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; SODIUM CHLORIDE; TINOSPORA CORDIFOLIA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; EUTHANASIA; FEMALE; IMMUNE RESPONSE; LUNG INJURY; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TINOSPORA;

ANIMALS; ENDOTOXEMIA; ENDOTOXINS; FEMALE; GLUCANS; IMMUNOLOGIC FACTORS; INJECTIONS, INTRAPERITONEAL; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; LUNG; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI; RATTUS; TINOSPORA CORDIFOLIA;

EID: 70350009664     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00447.x     Document Type: Article

References (36)

1. Rasmussen IT, Seljelid R. Novel immunomodulators with pronounced in vivo effects caused by stimulation of cytokine release. J Cell Biochem 1991 46 : 60 8.
2. Bellow M, Nelson R. Immunopharmacology, immunomodulation, and immunotherapy. JAMA 1997 278 : 2008 2017.
3. Tzianabos AO. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biological functions. Clin Microbiol Rev 2000 13 : 523 533.
4. Leyon PV, Kuttan G. Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals. Int Immunopharmacol 2004 4 : 1569 1575.
5. Singh N, Singh SM, Shrivastava P. Effect of Tinospora cordifolia on antitumor activity of tumor-associated macrophage-derived dendritic cells. Immunopharmacol Immunotoxicol 2005 27 : 1 14.
6. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE et al. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 2005 314 : 1079 1086.
7. Desai VR, Ramkrishnan R, Chintawar GJ, Sainis KB. G1-4A, an immunomodulatory polysaccharide from Tinospora cordifolia, modulates macrophage responses and protects mice against lipopolysaccharide induced endotoxemic shock. Int Immunopharmacol 2007 7 : 1375 1386.
8. Singh L, Tyagi S, Rizvi MA, Goel HC. Effect of Tinospora cordifolia on gamma ray-induced perturbations in macrophages and splenocytes. J Radiat Res (Tokyo) 2007 48 : 305 315.
9. Jagetia GC, Baliga MS. The evaluation of nitric oxide scavenging activity of certain Indian medicinal plants in vitro: a preliminary study. J Med Food 2004 7 : 343 348.
10. Nair PK, Rodriguez S, Ramachandran R et al. Immune stimulating properties of a novel polysaccharide from the medicinal plant Tinospora cordifolia. Int Immunopharmacol 2004 4 : 1645 1659.
11. Nair PK, Melnick SJ, Ramachandran R, Escalon E, Ramachandran C. Mechanism of macrophage activation by (1,4)-alpha-d-glucan isolated from Tinospora cordifolia. Int Immunopharmacol 2006 6 : 1815 1824.
12. Koppada R, Norozian FM, Torbati D, Kalomiris S, Ramachandran C, Totapally BR Physiologic effects of a novel immune stimulator drug, (1,4)-α-D- glucan, in rats. Basic Clin Pharmacol Toxicol (In press).
13. Brouwer A, Parker SG, Hendricks HF, Gibbons L, Horan MA. Production of eicosanoids and cytokines by Kupffer cells from young and old rats stimulated by endotoxin. Clin Sci (Lond) 1995 88 : 211 217.
14. Luce WA, Hoffman TM, Bauer JA. Bench-to-bedside review: Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis. Crit Care 2007 11 : 228.
15. Chan KL, Ho JC, Chan KW, Tam PK. A study of gut immunity to enteral endotoxin in rats of different ages: a possible cause for necrotizing enterocolitis. J Pediatr Surg 2002 37 : 1435 1440.
16. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C et al. Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am J Pathol 2001 159 : 1199 1209.
17. Bian K, Murad F. Diversity of endotoxin-induced nitrotyrosine in macrophage endothelium-rich organs. Free Radic Biol Med 2001 31 : 421 429.
18. Von Dossow Y, Rotard K, Redlich U, Hein OV, Spies CD. Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patient. Crit Care 2005 9 : 662 669.
19. Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care 2005 11 : 473 480.
20. Song M, Kellum JA. Interleukin-6. Crit Care Med 2005 33 (12 Suppl S463 5.
21. Lam HS, Ng PC. Biochemical markers of neonatal sepsis. Pathology 2008 40 : 141 148.
22. Opal SM. Endotoxin and cytokine detection systems as biomarkers for sepsis-induced renal injury. Contrib Nephrol 2007 156 : 220 226.
23. Simons RK, Junger WG, Loomis WH, Hoyt DB. Acute lung injury in endotoxemic rats is associated with sustained circulating IL-6 levels and intrapulmonary CINC activity and neutrophil recruitment - role of circulating TNF-α and IL-β. Shock 1996 6 : 39 45.
24. Hofstetter C, Flondor M, Hoegl S, Muhl H, Zwissler B. Interleukin-10 aerosol reduces proinflammatory mediators in bronchoalveolar fluid of endotoxemic rat. Crit Care Med 2005 33 : 2317 2322.
25. Novotny AR, Emmanuel K, Maier S, Westerholt A, Weighardt H, Stadler J et al. Cytochrome P450 activity mirrors nitric oxide levels in postoperative sepsis: predictive indicators of lethal outcome. Surgery 2007 141 : 376 384.
26. Tzianabos AO, Gibson FC III., Cisneros RL, Kasper DL. Protection against experimental sepsis by two polysaccharide immunomodulators. J Infect Dis 1998 178 : 200 206.
27. Soltys J, Quinn MT. Modulation of endotoxin-induced cytokine release by in vivo treatment with β-(1,6)-branched β-(1,3)-glucan. Infect Immun 1999 67 : 244 252.
28. Sherwood ER, Varma TK, Fram RY, Lin CY, Koutrouvelis AP, Toliver-Kinsky TE. Glucan phosphate potentiates endotoxin-induced interferon-γ expression in immunocompetent mice, but attenuates induction of endotoxin tolerance. Clin Sci 2001 101 : 541 550.
29. Brown GD, Gordon S. Fungal β-glucans and mammalian immunity. Immunity 2003 19 : 311 315.
30. Lowe EP, Wei D, Rice PJ et al. Human vascular endothelial cells express pattern recognition receptors for fungal glucans which stimulates nuclear factor κB activation and interleukin 8 production. Am Surg 2002 68 : 508 517.
31. Rice PJ, Lockhart BE, Baker LA, Adams EL, Ensley HE, Williams DL. Pharmacokinetics of fungal (1-3)-β-d-glucans following intravenous administration in rats. Int Immunopharmacol 2004 4 : 1209 1215.
32. + antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naïve and antigen-primed T cells. BMC Immunol 2008 9 : 4.
33. Hogaboam CM, Steinhauser ML, Schock H et al. Therapeutic effect of nitric oxide inhibitors during experimental fecal peritonitis: role of interleukin-10 and monocyte chemoattractant protein 1. Infect Immun 1998 66 : 650 655.
34. Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Streiter RM, Standiford TJ. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol 1999 162 : 392 399.
35. Booke M, Lingnau W, Hinder F, Traber LD, Traber DL. Endotoxin versus bacteremia: a comparison focusing on clinical relevance. Prog Clin Biol Res 1995 392 : 303 403.
36. Taylor FB Jr. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of elements of the compensated response and their links to the corresponding uncompensated lethal variants. Crit Care Med 2001 29 : S78 89.